MARKET

NNVC

NNVC

NANOVIRICIDES
AMEX

Real-time Quotes | Nasdaq Last Sale

3.820
+0.010
+0.26%
Closed 19:32 09/25 EDT
OPEN
3.830
PREV CLOSE
3.810
HIGH
3.900
LOW
3.750
VOLUME
148.16K
TURNOVER
--
52 WEEK HIGH
19.20
52 WEEK LOW
1.271
MARKET CAP
40.70M
P/E (TTM)
-1.4029
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
NanoViricides Nominates a Novel Candidate for Advancing Into Clinical Trials for Treatment of COVID-19
SHELTON, CT / ACCESSWIRE / September 16, 2020 / NanoViricides, Inc.
ACCESSWIRE · 09/16 11:15
NanoViricides is Developing Drugs Against SARS-CoV-2 with an Integrated Approach to Combat COVID-19, as Reported at The LD 500 Virtual Conference
SHELTON, CT / ACCESSWIRE / September 4, 2020 / NanoViricides, Inc.
ACCESSWIRE · 09/04 10:50
Fulgent Genetics leads healthcare gainers; Akebia Therapeutics and NanoViricides among losers
Gainers: Fulgent Genetics (FLGT) +20%. TRACON Pharmaceuticals (TCON) +17%. Applied Genetic Technologies (AGTC) +12%. CNS Pharmaceuticals (CNSP) +11%. Sutro Biopharma (STRO) +11%.Losers: Akebia Therapeutics (AKBA) -72%. T2 Biosystems (TTOO) -13%.Adaptive Biotechnologies (ADPT) -11%. NanoViricides (NNVC) -11%. Baudax Bio
Seekingalpha · 09/03 15:04
Benzinga Pro's Top 5 Stocks To Watch For Thursday, Sept. 3, 2020: DKNG, AKBA, CORT, NNVC, SWBI
Today's 5 Stock Ideas:  DraftKings (DKNG) - The company announced the Chicago Cubs  named D its first official and exclusive sports betting and daily fantasy partner. Shares were up about a half
Benzinga · 09/03 12:00
AGTC, FIVE, ZUO and PD among after-hours movers
Gainers: [[AGTC]] +14.0%. [[NNVC]] +12.5%. [[FLGT]] +9.8%. [[SPXC]] +9.4%. [[FIVE]] +8.1%.Losers: [[PD]] -23.1%. [[ZUO]] -17.3%. [[CYCN]] -9.2%. [[PDLI]] -8.0%. [[PLCE]] -6.9%.
Seekingalpha · 09/02 21:41
AMRN, VXRT, HOME and GOGO among midday movers
Gainers: Corcept Therapeutics (CORT) +35%.Vera Bradley (VRA) +29%.NanoViricides (NNVC) +27%.Gogo (GOGO) +25%.TSR (TSRI) +24%.Flying Eagle Acquisition (FEAC) +23%.SmileDirectClub (SDC) +19%.Vaxart (VXRT) +18%.Clearfield (CLFD) +16%.Lazydays (LAZY) +15%.Losers: Amarin (AMRN) -28%.At Home Group (HOME) -26%.Jiayin (JFIN) -24%.ADiTx Therapeutics (ADTX) -18%.GSX
Seekingalpha · 09/02 16:43
SmileDirectClub, NanoViricides leads healthcare gainers, Aptorum, ADiTx Therapeutics among major losers
Gainers: SmileDirectClub (SDC) +23%, NanoViricides (NNVC) +17%, Entasis Therapeutics Holdings (ETTX) +15%, Nano-X Imaging (NNOX) +14%, Oak Street Health (OSH) +12%.Losers: Aptorum Group (APM) -18%, ADiTx Therapeutics (ADTX) -16%, Amarin Corporation (AMRN) -13.4%, Acutus Medical AFIB -13.3%, ASLAN Pharmaceuticals (ASLN) -11%.
Seekingalpha · 09/02 15:08
SmileDirectClub rallies on CEO boosting stake, NanoViricides surged on announcement of provide COVID-19 drug update on September 3, Aptorum stumbles on 1H results, ADiTx Therapeutics traded under pressure on pricing follow-on public offering
Gainers: SmileDirectClub (SDC) +23%, NanoViricides (NNVC) +17%, Entasis Therapeutics Holdings (ETTX) +15%, Nano-X Imaging (NNOX) +14%, Oak Street Health (OSH) +12%.Losers: Aptorum Group (APM) -18%, ADiTx Therapeutics (ADTX) -16%, Amarin Corporation (AMRN) -13.4%, Acutus Medical AFIB -13.3%, ASLAN Pharmaceuticals (ASLN) -11%.
Seekingalpha · 09/02 15:08
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NNVC. Analyze the recent business situations of NANOVIRICIDES through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Price Target
The average NNVC stock price target is 0.6000 with a high estimate of 0.6000 and a low estimate of 0.6000.
EPS
Institutional Holdings
Institutions: 38
Institutional Holdings: 3.05M
% Owned: 28.59%
Shares Outstanding: 10.66M
TypeInstitutionsShares
Increased
3
85.77K
New
2
25.06K
Decreased
6
173.75K
Sold Out
4
1.42M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+3.04%
Pharmaceuticals & Medical Research
+1.58%
Key Executives
Chairman/President/Director
Anil Diwan
Chief Financial Officer
Meeta Vyas
Independent Director
Stanley Glick
Independent Director
Makarand Jawadekar
Independent Director
Theodore Rokita
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About NNVC
NanoViricides, Inc. is a nano-biopharmaceutical research and development company. The Company is engaged the discovery, development, and commercialization of drugs to combat viral infections using its nanomedicines technology. The Company provides nanoviricide technology, which enables direct attacks at multiple points on a virus particle. The nanoviricide technology is engaged in both attacking extracellular virus thereby breaking the reinfection cycle, and simultaneously disrupting intracellular production of the virus, thereby enabling complete control of a virus infection. The nanoviricide technology also simultaneously enables attacking the intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The Company’s lead product candidate is NV-HHV-101 in the HerpeCide program, as a skin cream for the treatment of shingles rash.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of NanoViricides Inc stock information, including AMEX:NNVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NNVC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NNVC stock methods without spending real money on the virtual paper trading platform.